Maternal Opioid Misuse (MOM) Initiative

Maternal Opioid Misuse Model Overview

Maine has received $5.3 million in federal funds as one of 10 states selected by the Centers for Medicare and Medicaid Services (CMS) to participate in the Maternal Opioid Misuse (MOM) model, which aims to improve care for pregnant and postpartum women with Opioid Use Disorder (OUD) and their infants.

Under the model, Maine will take steps to create a statewide system of evidence-based and comprehensive care for women with substance use disorders through MaineCare, the state's Medicaid health coverage program for low-income residents. The goal is to increase access to high-quality treatment and reduce costs while better coordinating and integrating care.

The Office of MaineCare Services will collaborate with six care delivery partners to pursue this model statewide:

  • MaineGeneral Medical Center
  • MaineHealth
  • Mid Coast-Parkview Hospital
  • Northern Light Health
  • Penobscot Community Health Care
  • Pines Health Services

The grant period is for five years, and DHHS anticipates expanding to additional sites over that time. By the third year of this initiative, DHHS plans to have established a sustainable way to fund through MaineCare the services necessary to support this care model moving forward.

Critical components of the MOM model include creating a "no wrong door" system to screening, welcoming and engaging women in care; supporting the treatment and recovery of mothers with group-based medication-assisted treatment; increasing the capacity of integrated care teams to deliver evidence-based care, including through telehealth; coordinating delivery, hospital, and post-partum care for mothers and infants; enhancing home visiting and community supports; and conducting a public outreach campaign.

The award addresses a critical need for Maine families, communities, and providers. In state fiscal year 2018, the DHHS Office of Child and Family Services received 904 reports regarding infants born exposed to substances, including opioids, which accounts for about 7 percent of live births in Maine. While this represents an ongoing decrease since 2014 and includes babies born to mothers who are on recommended medication-assisted treatment, infants exposed to opioids before birth are at a higher risk of being born early and with lower birth weights.

More information about the Maternal Opioid Misuse model, including a fact sheet and list of participants, can be found at:

Press Release 1/7/2020: Maine DHHS Wins $5.3M Federal Award to Help Mothers and Babies Affected by the Opioid Crisis